This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

 
Web www.patentalert.com

< Oxalamide derivatives as kinase inhibitors

> Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A.sub.2B adenosine receptors

~ 00453